Skip to main content
. Author manuscript; available in PMC: 2016 Apr 5.
Published in final edited form as: Am J Psychiatry. 2015 Oct 16;173(1):44–52. doi: 10.1176/appi.ajp.2015.14101358

Figure 1. Microglial activity measured with PET in ultra high risk subjects, patients with schizophrenia and matched controls.

Figure 1

Significant difference between experimental (red) and control (blue) groups, ANCOVA (covarying for age and genotype). A: a (df=21 p=0.004), b (df=21 p=0.030), c (df=21 p=0.047); B: d (df=21 p<0.001), e (df=21 p=0.005), f (df=21 p=0.001); C representative [11C]PBR28 PET image from a subject from each group.